Prevalence and Risk Factors of Cerebral Small Vessel Disease in a Chinese Population-Based Sample
- PMID: 29886722
- PMCID: PMC6007292
- DOI: 10.5853/jos.2017.02110
Prevalence and Risk Factors of Cerebral Small Vessel Disease in a Chinese Population-Based Sample
Abstract
Background and purpose: Epidemiological data of cerebral small vessel disease (CSVD) in the general population of China are lacking. We report on the prevalence of lacunes, white matter hyperintensity (WMH), and cerebral microbleeds (CMBs) in a community-based sample in China and compare the results with those of other studies.
Methods: This was a cross-sectional analysis of the population-based Shunyi Study in China. A total of 1,211 stroke-free participants (mean age, 55.6±9.3 years; 37.4% men) with available 3 Tesla (3T) magnetic resonance images were included in this analysis. Demographic information and risk factor data were assessed. The overall and age-specific prevalence of lacunes, WMH, and CMBs was evaluated. Associations between cardiovascular risk factors and the presence of these lesions were analyzed by multiple logistic regression.
Results: Our study showed a prevalence of 14.5% for lacunes, 72.1% for periventricular hyperintensity (PVH), 65.4% for deep white matter hyperintensity (DWMH), and 10.6% for CMBs. When compared with other community-based samples, individuals in the same age group showed a higher burden of lacunes and a relatively lower prevalence of CMBs. Advanced age was independently associated with the prevalence of these CSVD markers, while the presence of hypertension increased the risk of lacunes, PVH/DWMH, and CMBs in deep or infratentorial locations.
Conclusions: A higher burden of lacunes but a relatively lower prevalence of CMBs was observed in this Chinese population. This notable result highlights the challenge of CSVD prevention in China. Chinese have a risk factor profile for CSVD similar to those in other populations.
Keywords: Cerebral small vessel disease; China; Cross-sectional studies; Prevalence; Risk factors.
Similar articles
-
Correlation Between Blood Glucose Level and Cerebral Small Vessel Disease Markers in Neurologically Asymptomatic, Nondiabetic Individuals.Aging Med (Milton). 2025 Apr 18;8(2):117-125. doi: 10.1002/agm2.70017. eCollection 2025 Apr. Aging Med (Milton). 2025. PMID: 40353052 Free PMC article.
-
Implication of heart rate variability on cerebral small vessel disease: A potential therapeutic target.CNS Neurosci Ther. 2023 May;29(5):1379-1391. doi: 10.1111/cns.14111. Epub 2023 Feb 14. CNS Neurosci Ther. 2023. PMID: 36786131 Free PMC article.
-
Prevalence and Risk Factors of Cerebral Small Vessel Disease from a Population-Based Cohort in China.Neuroepidemiology. 2023;57(6):413-422. doi: 10.1159/000533678. Epub 2023 Sep 21. Neuroepidemiology. 2023. PMID: 37734325
-
Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.Ageing Res Rev. 2018 Nov;47:41-48. doi: 10.1016/j.arr.2018.06.002. Epub 2018 Jun 26. Ageing Res Rev. 2018. PMID: 29898422
-
Left Ventricular Hypertrophy and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.J Stroke. 2020 May;22(2):206-224. doi: 10.5853/jos.2019.03335. Epub 2020 May 31. J Stroke. 2020. PMID: 32635685 Free PMC article.
Cited by
-
Advance of antithrombotic treatment in patients with cerebral microbleed.J Thromb Thrombolysis. 2021 Feb;51(2):530-535. doi: 10.1007/s11239-020-02213-5. Epub 2020 Jul 6. J Thromb Thrombolysis. 2021. PMID: 32632557 Review.
-
Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.BMC Med Imaging. 2022 Mar 9;22(1):40. doi: 10.1186/s12880-022-00769-7. BMC Med Imaging. 2022. PMID: 35264145 Free PMC article.
-
Extracellular Vesicles Play a Central Role in Cerebral Venous Disease-Associated Brain Atrophy.Adv Sci (Weinh). 2023 Sep;10(27):e2301574. doi: 10.1002/advs.202301574. Epub 2023 Jul 12. Adv Sci (Weinh). 2023. PMID: 37438638 Free PMC article.
-
Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds.JAMA Netw Open. 2024 Oct 1;7(10):e2439571. doi: 10.1001/jamanetworkopen.2024.39571. JAMA Netw Open. 2024. PMID: 39405058 Free PMC article.
-
Decreased visible deep medullary veins is a novel imaging marker for cerebral small vessel disease.Neurol Sci. 2020 Jun;41(6):1497-1506. doi: 10.1007/s10072-019-04203-9. Epub 2020 Jan 18. Neurol Sci. 2020. PMID: 31955350
References
-
- Vermeer SE, Longstreth WT, Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611–619. - PubMed
-
- Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CL. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88:669–674. - PubMed
-
- Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157–165. - PubMed
-
- van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–176. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources